November 24, 2014 7:51 PM ET

Healthcare Equipment and Supplies

Company Overview of Aesculap, Inc.

Company Overview

Aesculap, Inc. supplies surgical instruments, implants, and supplies. It offers bipolar forceps, aneurysm clips, cranial fixation, dura substitutes, hydrocephalus shunts, neurosurgical instruments, neuroendoscopy, and spine implants for neurosurgery applications; power systems, such as cardiac and thoracic, maxilofacial plastics, neurosurgery, small bone, and spine products; and surgical instruments, including cardiovascular instruments, electrosurgery, general surgical instruments, laparoscopy, sterile processing products and services for green healthcare, neuro instruments, and retraction systems. The company also provides wound closure products, including surgical sutures, mechanical sutu...

3773 Corporate Parkway

Center Valley, PA 18034

United States

Founded in 1974





Key Executives for Aesculap, Inc.

Vice President of Biologics
Compensation as of Fiscal Year 2014.

Aesculap, Inc. Key Developments

Aesculap, Inc. Announces Caiman® 5 Seal and Cut Technology Line Extension

Aesculap, Inc. announced the expansion of its Caiman® 5 Seal and Cut Technology. A tool for open surgery procedures, the Caiman 5mm vessel sealer device will be available in two additional lengths to accommodate a variety of patient sizes for laparoscopic surgery. Caiman's novel hinged-jaw design and extended jaw offers unparalleled benefits for a broad range of procedures in the areas of gynecology, general and urologic surgery. Caiman was developed to address the challenges that come with traditional vessel sealing devices. For a variety of tissue thicknesses, the proprietary hinged jaw provides uniform pressure distribution across the surface of the tissue, resulting in a clean and consistent seal. Caiman Seal and Cut Technology consists of dedicated bipolar electrosurgical instruments intended for use in general surgery and gynecologic surgical procedures where ligation and division of vessels is desired. The instruments create a seal by the application of bipolar electrosurgical RF energy (coagulation) to vascular structure (vessels) interposed between the jaws of the device. A cutting blade is actuated for the division of tissue.

Aesculap, Inc. Launches Lyoplant Onlay Dura Substitute

Aesculap, Inc. announced the availability of Lyoplant Onlay, a biological, collagen based, absorbable dura substitution consisting of a bilayer membrane, designed to provide an elevated ease of use. The revolutionary product allows for a simple onlay application with the opportunity to incorporate suture fixation, if necessary. Reliable: Helps protect against CSF leakage, Excellent resorption rates, Superior tensile strength, 10x stronger than Suturable DuraGen and Strong biocompatibility. Simple: Familiar use, Time-saving onlay application, Convenient handling and Superior suture pull-out, 10x stronger than Suturable DuraGen. Versatile: Multi-use: Onlay or Suturable, 40% thinner than Suturable DuraGen, Excellent elasticity and flexibility and helps prevent cortical adhesion. Lyoplant Onlay is indicated as a dura substitute for the repair of the dura mater.

Aesculap, Inc. Announces the Launch of Miethke proSA

Aesculap, Inc. announced the launch of the Miethke proSA, an adjustable, gravitational shunt valve which offers surgeons treating Hydrocephalus the most flexible shunt system available, allowing the surgeon to provide the best treatment options to their patients. Like other valves in the Aesculap-Miethke line, proSA is a gravitational valve, which means it provides resistance to cerebral spinal fluid (CSF) flow in the upright position. Implanted in combination with fixed or adjustable valves, proSA allows surgeons to provide their patients with distinctly different pressure settings for the lying and the upright positions, thereby reducing the symptoms that are experienced when intracranial pressures (ICP's) are too low or too high. proSA is adjustable, which allows the upright pressure to be managed independently from the lying pressure. This eliminates the need to find a 'middle road' between optimal lying and standing pressures, reducing patient symptoms and allowing patients to lead as close to a symptom-free life as possible. The wide adjustability range from 0-40 cmH2O enables surgeons to manage the needs of a wide selection of patient types or patient needs such as height or weight changes. proSA's resistance can be reduced to zero if a gravitational valve is not needed, or increased if more resistance is required. With a maximum setting of 40 cmH2O, proSA, when combined with a fixed or adjustable valve, gives surgeons the opening pressure available for the upright positions. proSA's integrated Active-Lock MR brake helps prevent the valve from inadvertent pressure adjustments in 1.5 and 3T MRI scanners, and the need for re-adjustments after an MRI.

Similar Private Companies By Industry

Company Name Region
Protos Eyewear United States
Diagnostic Solutions of America, LLC United States
KeyMed, Inc. United States
Fresca Medical, Inc. United States
Choctaw-Kaul Distribution Company United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aesculap, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at